Yeast Genetics and Molecular Biology 2002
University of Wisconsin
Madison, Wisconsin USA
July 30 - August 4, 2002


Name: Meneghini, Marc
Mailing Address: Biochemistry and Biophysics, University of California SF, 513 Parnassus Avenue, San Francisco, CA 94143, USA
Email Address: marcmen@itsa.ucsf.edu
Phone & FAX numbers: 415-514-0596 & 415-731-3612

Abstract #11


Session Title: Chromosome Dynamics
Session Time: Wednesday, July 31 -- 9:00AM - 10:30AM
Presentation: Platform
Topic: Gene Expression

Negative Regulation of Sir-dependent Silencing by a Universally Conserved Histone Variant.
Marc Meneghini (1), Shivkumar Venkatasubrahmanyam (1), Michelle Wu (1), William Hwang (1), Amy Tong (2), Charlie Boone (2), Hiten Madhani (1)
(1) Biochemistry and Biophysics, University of California SF, 513 Parnassus Avenue, San Francisco, CA 94143, USA; (2) Banting and Best Department of Medical Research, University of Toronto, 112 College St., Toronto, ON M5G 1L6, Canada

Despite recent progress in identifying the mechanisms by which Sir-dependent gene silencing initiates and spreads, relatively little is known about how this presumably autocatalytic process is inhibited. We investigated the function of the poorly understood yet universally conserved histone variant H2A.Z (encoded by HTZ1 in yeast), which replaces H2A in 10% of nucleosomes. Microarray analysis revealed that H2A.Z-dependent genes cluster strikingly near telomeres suggesting that H2A.Z insulates these genes from telomeric silencing. Consistent with this model, the expression defect of half of these genes was reversed by removal of the histone deacetylase Sir2. In addition, the expression defect in htz1delta of a cluster of genes proximal to the HMR silent cassette can be reversed by either deletion of SIR2 or a deletion of HMR that includes the silencers. These data suggest that, in htz1 cells, silencing spreads from HMR to the adjacent region. Quantitative chromatin immunoprecipitation analysis of the disribution of Sir2 and histone acetylation in the HMR-proximal region and a strongly anti-silenced telomeric region supports this view. A genome-wide screen identified >20 genes whose deletion produces a synthetic lethal or very sick phenotype with htz1delta. One of these, SIF2 (Sir4-interacting factor 2), is a known antagonist of silencing. Consistent with the anti-silencing model, the severe growth defect of htz1 sif2 can be partially suppressed by deletions of SIR2 or SIR3.


Return to YGM 2002 Home at SGD